NCT00809549View on ClinicalTrials.gov

Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Ischemic Stroke
Interventions
DRUG

Filgrastim

10 ug/kg sc once daily x 4 days. Repeated once, 6 weeks later.

Trial Locations (2)

K1Y 4E9

The Ottawa Hospital, Ottawa

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER